Skip to content

GRAIL, Inc. GRAL Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Abbott logo
AbbottABT
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA
GeneDx Holdings logo
GeneDx HoldingsWGS
Celcuity logo
CelcuityCELC
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s common stock, shares authorized (in shares)?
GRAIL, Inc. (GRAL) reported common stock, shares authorized (in shares) of $1.5B in Q1 2026.
How has GRAIL, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
GRAIL, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $1.5B to $1.5B.
What is the long-term trend for GRAIL, Inc.'s common stock, shares authorized (in shares)?
Over 2 years (2023 to 2025), GRAIL, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $1.5B to $1.5B.